From July 1, 2023 to September 20, 2023, the company has repurchased 7,669,100 shares, representing 0.64% for CNY 81.02 million. With this, the company has completed the repurchase of 18,489,100 shares, representing 1.55% for CNY 194.73 million under the buyback announced on September 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 CNY | -1.87% | -1.76% | -10.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.36% | 1.37B | |
+30.53% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.34% | 239B | |
+9.54% | 211B | |
-3.03% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.